Skip to main contentSkip to navigation
Sirius Investors
10x Genomics, Inc.

10x Genomics, Inc.

TXG
NASDAQHealthcare

Revenue Analysis - TXG

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

TXG Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Product And Service Revenue

0.0% of total revenue

$149.9M

Consumables

0.0% of total revenue

$129.8M

Instruments

0.0% of total revenue

$11.3M

Service

0.0% of total revenue

$8.8M

Licensing And Royalty Revenue

0.0% of total revenue

$947.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Consumables
Instruments
Licensing And Royalty Revenue
Product And Service Revenue
Service
3/31/2026$129.8M$11.3M$947.0K$149.9M$8.8M
12/31/2025$141.8M$15.5M$341.0K$165.7M$8.5M
9/30/2025$127.9M$12.0M$983.0K$148.0M$8.1M
6/30/2025$122.2M$14.5M$27.8M$145.2M$8.5M
3/31/2025$115.4M$14.8M$17.1M$137.8M$7.7M
12/31/2024$256.9M$48.2M$0$0$13.0M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Growing Segments
Licensing And Royalty Revenue+177.7%
Declining Segments
Instruments-27.2%

Geographic Regions

Growing Regions
Asia-Pacific, Excluding China+17.5%
Declining Regions
UNITED STATES-71.5%
EMEA-31.1%

Earnings Reports

Want to see how TXG's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports